Human SOX9 quantitates human SOX9 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human SOX9.
Human SOX9 quantitates human SOX9 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human SOX9.
SOx9 plays a role in the sexual determination and differentiation of Sertoli cells. It is involved in chondrogenesis and regulates the expression of other genes involved in chondrogenesis by acting as transcription factor for these genes. Translocation of this gene can cause campomeric dysplasia. SOx9 is involved in the formation of testicles of indifferent foetal gonads. It is a major molecular component of neurone-glie switching in spinal cord development. During normal development, SOX9 allows prostate epithelium to develop in mesenchyma, and then provides basal cell support for the development and maintenance of luminal epithelium. These SOX9 functions are subverted into prostate cancer to promote tumour growth and invasion. SOx9 can direct the formation of neural peak precursors and the development of a range of neural peak derivatives. It has transcriptional regulation in the production of melanin in cells. Northern transfer analysis shows its expression on adult testicles, adult heart and fetal brain.
Sensitivity
Sensitivity of dosage: 0.41 ng/ml.
Measurement range
Dose range: 0.41 to 100 ng/ml.
Duration of dosing
Total duration of dosing: 4 h 45 min.
Samples
Sample type: Plasma, Serum, Surnatant (Serum volume, 50 µl; Supernatant, 50 µl; Plasma, 50 µl).
Technical specifications
| General |
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 17155219 |
| Specifications |
| Accession number | 2010306G03Rik; AV220920; CMD1; CMPD1; mKIAA4243; SOX 9; So x 9; SOX-9; SRA1; SRX x 2; SRXY10; SRY (Y sex determination region)-box 9; SRY (Y sex determination region)-box 9 (campomeric dysplasia, autosomal sexual inversion); SRY (gender determination region Y |
| Dose range | 0.41 to 100 ng/ml |
| Sensitivity of the dosage | 0.41 ng/ml |
| Conjugate | Biotin |
| Product type | ELISA |
| Type of sample | Plasma, Serum, Surnatant |
| For use with (equipment) | Colorimetric microplate reader |
| Genetic identification (Enter) | P48436 |
| Gene symbol(s) | SOX9 |
| Coefficient of inter-dose variation | <12% |
| Coefficient of intra-dose variation | <10% |
| Contents of kits | 96 pre-coated well plate, standard, dosing diluent concentrate, biotinylated detection antibody, SAV-HRP, washing pad, chromogen, stop solution, adhesive plate lids |
| Marker or dye | HRP |
| Quantity | 5 x 96 tests |
| Regulatory status | Use exclusively for research |
| Target | SOX9 |
| Test time | 1 h 20 min |
| Physical characteristics |
| Volume of sample | Serum, 50 µl; Supernatant, 50 µl; Plasma, 50 µl |
| Storage and shipping |
| Storage conditions | 2°C to 8°C |
| Total duration of dosing | 4 h 45 min |
Origin and customs
| Manufacturer ref. | EH435RBX5 |
|---|
| Country of origin | United States |
|---|
A question or a specific configuration?
Contact us for a quote.